This study included two eyes with less advanced disease (Group B and C) and three with an absence of vitreous seeding, yet detectable levels of tumor-derived cfDNA were identified in every diagnostic sample of AH based either on the identification of SCNAs, pathogenic RB1 SNVs, or both. The gene discussed is RB1; the disease is neoplasm.